Abstract
In recent years, the number of counterfeit drugs has increased dramatically, including not only “lifestyle” products but also vital medicines. Besides the threat to public health, the financial and reputational damage to pharmaceutical companies is substantial. The lack of robust information on the prevalence of fake drugs is an obstacle in the fight against drug counterfeiting. It is generally accepted that approximately 10% of drugs worldwide could be counterfeit, but it is also well known that this number covers very different situations depending on the country, the places where the drugs are purchased, and the definition of what constitutes a counterfeit drug. The chemical analysis of drugs suspected to be fake is a crucial step as counterfeiters are becoming increasingly sophisticated, rendering visual inspection insufficient to distinguish the genuine products from the counterfeit ones. This article critically reviews the recent analytical methods employed to control the quality of drug formulations, using as an example artemisinin derivatives, medicines particularly targeted by counterfeiters. Indeed, a broad panel of techniques have been reported for their analysis, ranging from simple and cheap in-field ones (colorimetry and thin-layer chromatography) to more advanced laboratory methods (mass spectrometry, nuclear magnetic resonance, and vibrational spectroscopies) through chromatographic methods, which remain the most widely used. The conclusion section of the article highlights the questions to be posed before selecting the most appropriate analytical approach.
Similar content being viewed by others
References
Europharm Forum (2009) Framework for a guide on counterfeit medicines for pharmacists. http://www.europharm.org/file/11800. Accessed 6 Feb 2010
World Health Organization (1999) WHO counterfeit drugs. Guidelines for the development of measures to combat counterfeit drugs, vol 99.1. World Health Organization, Geneva. http://www.who.int/medicines/publications/counterfeitguidelines/en/. Accessed 6 Feb 2010
Newton PN, Lee SJ, Goodman C, Fernandez FM, Yeung S, Phanouvong S, Kaur H, Amin AA, Whitty CJM, Kokwaro GO, Lindegardh N, Lukulay P, White LJ, Day NPJ, Green MD, White NJ (2009) PLoS Med 6:e1000052
World Health Organization (2008) WHO world malaria report-2008. http://www.who.int/malaria/wmr2008. Accessed 6 Feb 2010
Newton PN, Green MD, Fernandez FM, Day NPJ, White NJ (2006) Lancet Infect Dis 6:602–613
World Health Organization (2006) Guidelines for the treatment of malaria. http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf. Accessed 6 Feb 2010
Thomas CG, Ward SA, Edwards G (1992) J Chromatogr 583:131–136
Green MD, Mount DL, Wirtz RA, White NJ (2000) J Pharm Biomed Anal 24:65–70
Green MD, Mount DL, Wirtz RA (2001) Trop Med Int Health 6:980–982
Ioset JR, Kaur H (2009) PLoS One 4:e7270
Green MD, Nettey H, Rojas OV, Pamanivong C, Khounsaknalath L, Ortiz MG, Newton PN, Fernandez FM, Vongsack L, Manolin O (2007) J Pharm Biomed Anal 43:105–110
Atemnkeng MA, De Cock K, Plaizier-Vercammen J (2007) Trop Med Int Health 12:68–74
Atemnkeng MA, Marchand E, Plaizier-Vercammen J (2007) J Pharm Biomed Anal 43:727–732
Cesar IDC, Nogueira FHA, Pianetti GA (2008) J Pharm Biomed Anal 48:951–954
Gaudin K, Kauss T, Lagueny AM, Millet P, Fawaz F, Dubost JP (2009) J Sep Sci 32:231–237
Hall KA, Newton PN, Green MD, de Veij M, Vandenabeele P, Pizzanelli D, Mayxay M, Dondorp A, Fernandez FM (2006) Am J Trop Med Hyg 75:804–811
Lindegardh N, Dondorp AM, Singhasivanon P, White NJ, Day NPJ (2007) J Pharm Biomed Anal 45:149–153
Fernandez FM, Cody RB, Green MD, Hampton CY, McGready R, Sengaloundeth S, White NJ, Newton PN (2006) Chemmedchem 1:702–705
Nyadong L, Green MD, De Jesus VR, Newton PN, Fernandez FM (2007) Anal Chem 79:2150–2157
Nyadong L, Harris GA, Balayssac S, Galhena AS, Malet-Martino M, Martino R, Parry RM, Wang MD, Fernandez FM, Gilard V (2009) Anal Chem 81:4803–4812
Nyadong L, Late S, Green MD, Banga A, Fernandez FM (2008) J Am Soc Mass Spectrom 19:380–388
Ricci C, Nyadong L, Fernandez FM, Newton PN, Kazarian SG (2007) Anal Bioanal Chem 387:551–559
Ricci C, Nyadong L, Yang F, Fernandez FM, Brown CD, Newton PN, Kazarian SG (2008) Anal Chim Acta 623:178–186
Newton PN, Fernandez FM, Plançon A, Mildenhall DC, Green MD, Ziyong L, Christophel EM, Phanouvong S, Howells S, McIntosh E, Laurin P, Blum N, Hampton CY, Faure K, Nyadong L, Soong CWR, Santoso B, Zhiguang W, Newton J, Palmer K (2008) PLoS Med 5:e32
Ricci C, Eliasson C, Macleod NA, Newton PN, Matousek P, Kazarian SG (2007) Anal Bioanal Chem 389:1525–1532
Dowell FE, Maghirang EB, Fernandez FM, Newton PN, Green MD (2008) J Pharm Biomed Anal 48:1011–1014
de Veij M, Vandenabeele P, Hall KA, Fernandez FM, Green MD, White NJ, Dondorp AM, Newton PN, Moens L (2007) J Raman Spectrosc 38:181–187
Marchand E, Atemnkeng MA, Vanermen S, Plaizier-Vercammen J (2008) Biomed Chromatogr 22:454–459
Gabriels M, Plaizier-Vercammen J (2004) J Chromatogr Sci 42:341–347
Agarwal SP, Ali A, Ahuja S (2007) Indian J Pharm Sci 69:841–844
Tayade NG, Nagarsenker MS (2007) J Pharm Biomed Anal 43:839–844
Jahnke RWO (2004) Pharm Ind 66:1187–1193
Basco LK (2004) Am J Trop Med Hyg 70:245–250
Global Pharma Health Fund (2010) The GPHF-Minilab® - protection against counterfeit medicines. http://www.gphf.org/web/en/minilab. Accessed 7 Feb 2010
Ma C, Wang H, Lu X, Xu G, Liu B (2008) J Chromatogr A 1186:412–419
Peng CA, Ferreira JFS, Wood AJ (2006) J Chromatogr A 1133:254–258
Liu S, Tian N, Liu Z, Huang J, Li J, Ferreira JFS (2008) J Chromatogr A 1190:302–306
Liu S, Tian N, Li J, Huang J, Liu Z (2009) Biomed Chromatogr 23:1101–1107
Theoharides AD, Smyth MH, Ashmore RW, Halverson JM, Zhou ZM, Ridder WE, Lin AJ (1988) Anal Chem 60:115–120
Mohamed SS, Khalid SA, Ward SA, Wan TSM, Tang HPO, Zheng M, Haynes RK, Edwards G (1999) J Chromatogr B 731:251–260
Russo R, Guillarme D, Rudaz S, Bicchi C, Veuthey JL (2008) J Sep Sci 31:2377–2387
Ferreira JFS, Gonzalez JM (2009) Phytochem Anal 20:91–97
Souppart C, Gauducheau N, Sandrenan N, Richard F (2002) J Chromatogr B 774:195–203
Naik H, Murry DJ, Kirsch LE, Fleckenstein L (2005) J Chromatogr B 816:233–242
Sabarinath S, Singh RP, Gupta RC (2006) J Chromatogr B 842:36–42
Van Quekelberghe SAA, Soomro SA, Cordonnier JA, Jansen FH (2008) J Anal Toxicol 32:133–139
Anderson CA, Drennen JK, Ciurczak EW (2007) In: Burns DA, Ciurzak EW (eds) Handbook of near-infrared analysis. CRC, Boca Raton, pp 585–612
Eliasson C, Matousek P (2007) Anal Chem 79:1696–1701
Antalek B (2002) Concepts Magn Res 14:225–258
Trefi S, Gilard V, Balayssac S, Malet-Martino M, Martino R (2008) J Pharm Biomed Anal 46:707–722
Trefi S, Routaboul C, Hamieh S, Gilard V, Malet-Martino M, Martino R (2008) J Pharm Biomed Anal 47:103–113
Trefi S, Gilard V, Balayssac S, Malet-Martino M, Martino R (2009) Magn Reson Chem 47:S163–S173
Maurin JK, Plucinski F, Mazurek AP, Fijalek Z (2007) J Pharm Biomed Anal 43:1514–1518
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martino, R., Malet-Martino, M., Gilard, V. et al. Counterfeit drugs: analytical techniques for their identification. Anal Bioanal Chem 398, 77–92 (2010). https://doi.org/10.1007/s00216-010-3748-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-3748-y